Genzyme leads drug stocks higher By: MarketWatch August 30, 2010 at 10:45 AM EDT Genzyme Corp. was the lead advancer among the large-cap drug stocks in early trading, with shares rising almost 4% to $70.16. Read More >> Related Stocks: Immunogen Inc Macy's Sanofi-Aventis S.A. ADR